Out-Law / Your Daily Need-To-Know

Today's top story

Pharmaceutical companies face wait on EU AI regulation question

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the process of drug development need clarity on whether the rules will apply to them.

Artificial intelligence

Tailor your content

Most Read

About Out-Law

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.